Media OptraSCAN Announces CytoSiA

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening and detection of cervical cancer, …

OptraSCAN Announces CytoSiA – A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing Read More »

San Jose (California) [USA]/Pune (Maharashtra) [India], May 26 (ANI/PRNewswire): OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and …

OptraSCAN announces CytoSiA – A complete digital solution for scanning and analysis of cytology slides at affordable pricing Read More »

San Jose (California) [USA]/Pune (Maharashtra) [India], May 26 (ANI/PRNewswire): OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and …

OptraSCAN announces CytoSiA – A complete digital solution for scanning and analysis of cytology slides at affordable pricing Read More »

SAN JOSE, Califórnia, e PUNE, Índia, 26 de mayo de 2021 /PRNewswire/ — A OptraSCAN®, fornecedora líder de soluções em patologia digital sob demanda, anunciou hoje sua solução inteligente  CytoSiA para digitalização e análise rápida, mas acessível, de lâminas de citologia em meio líquido e Papanicolau. É uma solução completa composta por scanner digital de patologias, armazenamento e algoritmos …

OptraSCAN anuncia CytoSiA, uma solução digital completa para digitalização e análise de lâminas de citologia, a preços a Read More »

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN’s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening and detection of cervical cancer, …

OptraSCAN Announces CytoSiA – A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing Read More »

May 25, 2021 — OptraSCAN®, has released a new device called CytoSiA for scanning and analyzing liquid-based cytology slides and Pap smears. CytoSiA consists of the company’s digital pathology scanner, storage, and artificial intelligence (AI) algorithms for screening and detection of cervical cancer, precancerous lesions, and atypical cells. It can scan 15 x 15-mm cytology slides …

OptraScan launches cytology slide scanning device Read More »

加州圣荷塞和印度浦那2021年5月27日 /美通社/ — 全球领先的按需数字病理学解决方案提供商OptraSCAN®，今天宣布推出其智能解决方案CytoSiA，可快速而经济地扫描和分析液基细胞学切片和巴氏涂片。这是一项全面的解决方案，由OptraSCAN数字病理扫描仪、存储和强大的人工智能（AI）算法组成，可协助病理学家和细胞学技术专家筛查和检测宫颈癌、癌前期病变、非典型细胞及所有其他细胞学类别。全球多家医院和病理学实验室均已安装CytoSiA，并且见证了患者预后改善、效率提升以及为应对日益增长的细胞学病例需求所需的生产力 “OptraSCAN创始人Abhi Gholap表示，“OptraSCAN通过推出CytoSiA重新定义了宫颈癌筛查。CytoSiA可以提供大量的特征，以便能够有效地筛查液基细胞学切片和巴氏涂片，从而使用Bethesda分类法针对正常至鳞状细胞癌（NILM/LSIL/HSIL/SCC）区分正常和异常的宫颈细胞。” 他进一步补充道：“我们供应一系列扫描设备，每周可处理低至50-5000张不等的切片，价格极为低廉。” OptraSCANS数字扫描仪能在60秒内以40倍放大率扫描15×15毫米的细胞学切片，同时产生最高质量的图像。CytoSia采用专利技术——复合成像，可从各种Z平面图像中找到所有对焦像素，并重新拼接形成单层复合图像。与传统的Z堆叠技术相比，这种复合成像技术具有更高的效率。它可在数秒内对整张切片进行快速而准确的筛查。这种精度和质量水准对于样本分析而言至关重要。此外，它还会向筛查者呈现细胞学解释所必不可少的字段的图像，将它们进行分门别类，同时过滤掉冗余图像。 CytoSiA用作伴随式诊断工具时，倘若发现病理学家的解释与AI算法的结果存在不符，它会通知病理学家，从而防止出现错误或误解释，同时也提高整体护理质量。 CytoSiA功能： 自动计算整张切片细胞学图像的样本充分性 利用Bethesda评分，基于形态学特征和AI分类识别异常细胞和其他实体 识别反应性、子宫内膜、放线菌、念珠菌、线索细胞、阴道毛滴虫和疱疹实体 识别血液、炎症和润滑剂等实体 OptraSCAN医学总监Aparna Joshi博士表示，“基于AI的图像分析需要运用质量上乘的图像。” “我们的团队已经开发出一种智能成像技术，可将物理玻璃细胞学切片转化为清晰度甚佳的数字图像。目前，先进的图像分析和标准化可借助此种品质的数字化技术予以实现”，她进一步补充道。